Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma.
Andres F CorreaEkaterina KalashnikovaHsin-Ta WuRyan M WintersMustafa BalciogluSumedha SudhamanDenise C ConnollyYulan GongRobert G UzzoHimanshu SethiAdam C ElNaggarAlexey AleshinMinetta C LiuPhilip H AbboshPublished in: The oncologist (2024)
Detection of plasma ctDNA using a personalized assay is prognostic of recurrence in patients with resected RCC. Herein, we describe a successful approach for its application and identify potential limitations to be addressed in future studies.